BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/9/2024 1:59:13 PM | Browse: 282 | Download: 1038
 |
Received |
|
2023-11-14 05:37 |
 |
Peer-Review Started |
|
2023-11-14 05:39 |
 |
First Decision by Editorial Office Director |
|
2024-01-31 19:47 |
 |
Return for Revision |
|
2024-02-01 08:18 |
 |
Revised |
|
2024-02-08 05:33 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-03-14 02:43 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-03-14 04:24 |
 |
Articles in Press |
|
2024-03-14 04:24 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-22 04:49 |
 |
Publish the Manuscript Online |
|
2024-05-09 13:59 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen and Jun-Feng Du |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 81870393 |
|
| Corresponding Author |
Jun-Feng Du, MD, Adjunct Professor, Department of General Surgery, The 7th Medical Center of PLA General Hospital, No. 5 NanmenCang, Beijing 100700, China. dujunfeng@301hospital.com.cn |
| Key Words |
Rectal cancer; Metastasis; Chemoradiotherapy; Immunotherapy; Prognosis; Case report |
| Core Tip |
Rectal cancer is a clinically common malignancy and the mainstream treatment methods are chemoradiotherapy (CRT) and surgery. Advanced rectal cancer is often associated with distant organs and lymph node metastasis. We report a case of mismatch repair proficient rectal cancer with left supraclavicular lymph node metastasis. The patient received 4 cycles of CRT combined with immunotherapy and achieved PCR. This case provides a rare clinical experience for such patients. |
| Publish Date |
2024-05-09 13:59 |
| Citation |
Zhong WT, Lv Y, Wang QY, An R, Chen G, Du JF. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World J Gastrointest Oncol 2024; 16(5): 2219-2224 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i5/2219.htm |
| DOI |
10.4251/wjgo.v16.i5.2219 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.